DNase I is able to reduce autoimmunity to MPO with a reduced number of MPO specific lymphocytes (IL17a and IFNγ) in the draining lymph nodes and an increase in the number of MPO specific T regulatory cells, suggesting that DNase I may have an immunomodulatory role. The gene discussed is DNASE1L3; the disease is Autoimmunity.